AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 90 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $252 | -16.3% | 137,742 | -43.3% | 0.00% | 0.0% |
| Q4 2023 | $301 | -99.8% | 242,974 | +8.2% | 0.00% | 0.0% |
| Q1 2022 | $161,000 | -55.6% | 224,537 | +39.9% | 0.00% | -50.0% |
| Q4 2021 | $363,000 | -18.8% | 160,504 | +3.3% | 0.00% | -33.3% |
| Q3 2021 | $447,000 | -39.3% | 155,340 | -20.1% | 0.01% | -25.0% |
| Q2 2021 | $736,000 | +156.4% | 194,323 | +129.6% | 0.01% | +100.0% |
| Q1 2021 | $287,000 | +462.7% | 84,652 | +367.0% | 0.00% | – |
| Q4 2020 | $51,000 | – | 18,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 625,738 | $5,525,000 | 2.27% |
| Novo Holdings A/S | 3,100,000 | $27,373,000 | 2.17% |
| Nantahala Capital Management | 4,724,211 | $41,715,000 | 1.12% |
| Opus Point Partners Management, LLC | 45,004 | $397,000 | 0.95% |
| Stanley-Laman Group, Ltd. | 301,182 | $2,659,000 | 0.65% |
| Perceptive Advisors | 2,449,521 | $21,629,000 | 0.58% |
| Rubric Capital Management LP | 302,731 | $2,673,000 | 0.28% |
| Abrams Capital Management | 1,119,286 | $9,883,000 | 0.26% |
| Nantahala Capital Management | 851,000 | $7,515,000 | 0.20% |
| Spark Investment Management LLC | 300,000 | $2,649,000 | 0.15% |